Jump to: Authorized Access | Attribution | Authorized Requests

Study Description
It remains unknown if inherited germline mutations in the BRCA1 or BRCA2 gene increase the risk of breast and ovarian cancer by elevating mutation rate in mammary cells. Here we show, using a single-cell whole genome sequencing approach, that mammary luminal epithelial cells isolated from tissues obtained from preventive mastectomy surgeries in women with a pathogenic BRCA1/2 germline mutation, exhibit a statistically significant, increased mutation frequency as compared to age-matched controls without genetic risk of breast cancer.
Authorized Access
Publicly Available Data
  Link to other NCBI resources related to this study
Study Inclusion/Exclusion Criteria

Tissue samples included in the control group were obtained from women (mean age 40 SD+/-7.9) undergoing reduction mammoplasty for cosmetic reasons who reported no previous family history of breast cancer. The high breast cancer risk group included patients diagnosed with germline pathogenic mutations in BRCA1 or BRCA2 (mean age 41.1 SD+/-2.89); five tissues from the high risk group were collected from cancer-free female patients undergoing prophylactic tumor preventive mastectomy, three samples were non-tumor mammary tissue samples collected from patients diagnosed with early onset breast cancer.

Selected Publications
Diseases/Traits Related to Study (MeSH terms)
Authorized Data Access Requests
Study Attribution
  • Principal Investigators
    • Jan Vijg, PhD. Albert Einstein College of Medicine, Bronx, NY, USA.
    • Cristina Montagna, PhD. Albert Einstein College of Medicine, Bronx, NY, USA.